$1.66
-0.01-0.60%
At close: Dec 12, 4:00 PM EST
$1.68
0.021.20%
After Hours: Dec 11, 8:16 AM EST
Comments
Loading...
CytoMed Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GDTC | Benzinga
CytoMed Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$225.39K
Analyze the earnings history of CytoMed Therapeutics using advanced sorting and filters.
CytoMed Therapeutics (GDTC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
CytoMed Therapeutics (GDTC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is CytoMed Therapeutics (NASDAQ:GDTC) reporting earnings?
There are no earnings for CytoMed Therapeutics
What were the latest earnings per share (EPS) for CytoMed Therapeutics (NASDAQ:GDTC)?
There are no earnings for CytoMed Therapeutics
What were CytoMed Therapeutics’s (NASDAQ:GDTC) revenues?
There are no earnings for CytoMed Therapeutics
Browse earnings estimates, EPS, and revenue on all stocks.
